Clinical Trials

DermatologicGenitourinaryThoracic

1,800 enrolled

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT05038657 2022-10-03

AURORA

36 enrolled

Genitourinary

Carcinoma, Squamous Cell, Urologic Neoplasms

NCT05396937 2022-05-31

Efficacy and Safety of T+A+RAD in HCC

42 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT03262454 2022-04-06

Atezolizumab

35 enrolled

Small Cell Lung Cancer Recurrent

NCT03835949 2022-04-01

Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

Phase 1 Unknown

36 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05034055 2021-09-05

SKYROCKET

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04465942 2021-08-23

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

300 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04739202 2021-03-29

IMMUNOGAST

60 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT04696939 2021-01-06

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

100 enrolled

Small Cell Lung Carcinoma

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

130 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT04145232 2020-08-10

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

30 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

40 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

4,724 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04169867 2019-11-20

Polish Microbiome Map

1,160 enrolled

Dermatologic

Melanoma, Neoplasms

NCT03620435 2018-08-13

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

25 enrolled

Safety Issues

NCT03616691 2018-08-06

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

46 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03228368 2017-07-24

The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients

10 enrolled